Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.

[1]  D. Goldstein,et al.  Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers , 2006, European Journal of Clinical Pharmacology.

[2]  M. Jann,et al.  Pharmacokinetics of haloperidol and reduced haloperidol in chinese schizophrenic patients after intravenous and oral administration of haloperidol , 1992, Psychopharmacology.

[3]  J. Tukker,et al.  Bioavailibility of paracetamol after oral administration to healthy volunteers , 1986, Pharmaceutisch Weekblad.

[4]  M. Eichelbaum,et al.  Pharmacokinetics of oral and intravenous rifampicin during chronic administration , 1985, Klinische Wochenschrift.

[5]  D. W. Hawkins,et al.  Population pharmacokinetics of racemic warfarin in adult patients , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  W. L. Chiou,et al.  Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[7]  D. Greenblatt,et al.  Diazepam absorption , 1982, Digestive Diseases and Sciences.

[8]  Ulf Norinder,et al.  Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility , 2002, Pharmaceutical Research.

[9]  G. Amidon,et al.  Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine , 2001, Pharmaceutical Research.

[10]  Lawrence X. Yu.  An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.

[11]  D. Fleisher,et al.  Meal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients , 1999, Pharmaceutical Research.

[12]  Hans Lennernäs,et al.  Jejunal Absorption and Metabolism of R/S-Verapamil in Humans , 1998, Pharmaceutical Research.

[13]  G. Amidon,et al.  Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion , 1997, Pharmaceutical Research.

[14]  Hans Lennernäs,et al.  Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.

[15]  R. J. Talbot,et al.  The bioavailability of26Al-labelled aluminium citrate and aluminium hydroxide in volunteers , 1996, Biometals.

[16]  M. Bogaert.  Clinical pharmacokinetics of nitrates , 1994, Cardiovascular Drugs and Therapy.

[17]  J. Seibold,et al.  Pharmacokinetics and Bioinversion of Ibuprofen Enantiomers in Humans , 1994, Pharmaceutical Research.

[18]  J. S. Lee,et al.  Biopharmaceutics of Didanosine in Humans and in a Model for Acid-Labile Drugs, the Pentagastrin-Pretreated Dog , 1993, Pharmaceutical Research.

[19]  G. Flynn,et al.  Solubility Behavior of Narcotic Analgesics in Aqueous Media: Solubilities and Dissociation Constants of Morphine, Fentanyl, and Sufentanil , 1989, Pharmaceutical Research.

[20]  P. Hartvig,et al.  Pharmacokinetics and oral bioavailability of pyridostigmine in man , 1980, European Journal of Clinical Pharmacology.

[21]  P. Neuvonen,et al.  Pharmacokinetics of metformin after intravenous and oral administration to man , 1979, European Journal of Clinical Pharmacology.

[22]  M. Rawlins,et al.  Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration , 1977, European Journal of Clinical Pharmacology.

[23]  T. Talseth.  Studies on hydralazine , 1976, European Journal of Clinical Pharmacology.

[24]  A. Rane,et al.  The postoperative pharmacokinetics of codeine , 2004, European Journal of Clinical Pharmacology.

[25]  Alex Avdeef,et al.  pH-Metric Solubility. 2: Correlation Between the Acid-Base Titration and the Saturation Shake-Flask Solubility-pH Methods , 2004, Pharmaceutical Research.

[26]  A. Somogyi,et al.  Evaluation of the Intestinal Absorption of Erythromycin in Man: Absolute Bioavailability and Comparison with Enteric Coated Erythromycin , 2004, Pharmaceutical Research.

[27]  D. Perrier,et al.  Allopurinol kinetics and bioavailability , 2004, Cancer Chemotherapy and Pharmacology.

[28]  J. Scherrmann,et al.  Pharmacokinetics and absolute bioavailability of colchicine after i. v. and oral administration in healthy human volunteers and elderly subjects , 2004, European Journal of Clinical Pharmacology.

[29]  D. Palm,et al.  Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man , 2004, European Journal of Clinical Pharmacology.

[30]  K. Midha,et al.  Pharmacokinetics of chlorpromazine and key metabolites , 2004, European Journal of Clinical Pharmacology.

[31]  J. Karlsen,et al.  Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally , 2004, European Journal of Clinical Pharmacology.

[32]  V. Steinijans,et al.  Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions , 2004, European Journal of Clinical Pharmacology.

[33]  J. Bircher,et al.  Increased systemic availability of albendazole when taken with a fatty meal , 2004, European Journal of Clinical Pharmacology.

[34]  R. Grimaldi,et al.  Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects , 2004, European Journal of Clinical Pharmacology.

[35]  D. Bateman,et al.  Oral bioavailability of high-dose metoclopramide , 2004, European Journal of Clinical Pharmacology.

[36]  L. Paalzow,et al.  Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis , 2004, European Journal of Clinical Pharmacology.

[37]  A. Grahnén,et al.  Implications of intraindividual variability in bioavailability studies of furosemide , 2004, European Journal of Clinical Pharmacology.

[38]  P. Grøttum,et al.  Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration , 2004, European Journal of Clinical Pharmacology.

[39]  H. Breithaupt,et al.  Kinetics of allopurinol after single intravenous and oral doses , 2004, European Journal of Clinical Pharmacology.

[40]  J. Mccafferty,et al.  Bioavailability of oral dexamethasone during high dose steroid therapy in neurological patients , 2004, European Journal of Clinical Pharmacology.

[41]  M. Eichelbaum,et al.  Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil , 2004, European Journal of Clinical Pharmacology.

[42]  S. Vandel,et al.  Biotransformation of amitriptyline in depressive patients: Urinary excretion of seven metabolites , 2004, European Journal of Clinical Pharmacology.

[43]  W. L. Chiou,et al.  Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults , 2004, European Journal of Clinical Pharmacology.

[44]  T. Talseth.  Studies on hydralazine , 2004, European Journal of Clinical Pharmacology.

[45]  U. Bondesson,et al.  Pharmacokinetics of haloperidol in psychotic patients , 2004, Psychopharmacology.

[46]  D. G. Herries,et al.  The demethylation of amitriptyline administered by oral and intramuscular routes , 2004, Psychopharmacology.

[47]  Christel A. S. Bergström,et al.  Absorption classification of oral drugs based on molecular surface properties. , 2003, Journal of medicinal chemistry.

[48]  Alberto Guenzi,et al.  Improvement of the Bioavailability of Colchicine in Rats by Co-administration of D-α-Tocopherol Polyethylene Glycol 1000 Succinate and a Polyethoxylated Derivative of 12-Hydroxy-Stearic Acid , 2002, Arzneimittelforschung.

[49]  T. Wiedmann,et al.  Examination of the solubilization of drugs by bile salt micelles. , 2002, Journal of pharmaceutical sciences.

[50]  P. Watkins,et al.  Hepatic but not intestinal CYP3A4 displays dose‐dependent induction by efavirenz in humans , 2002, Clinical pharmacology and therapeutics.

[51]  P. Finglas,et al.  Use of an oral/intravenous dual-label stable-isotope protocol to determine folic acid bioavailability from fortified cereal grain foods in women. , 2002, The Journal of nutrition.

[52]  G. Amidon,et al.  The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[53]  Y. Ishihama,et al.  A rapid method for pKa determination of drugs using pressure-assisted capillary electrophoresis with photodiode array detection in drug discovery. , 2002, Journal of pharmaceutical sciences.

[54]  R. Kim,et al.  The anthelminthic agent albendazole does not interact with p-glycoprotein. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[55]  R. Koopmans,et al.  Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. , 2002, The American journal of tropical medicine and hygiene.

[56]  Arun K Mandagere,et al.  Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. , 2002, Journal of medicinal chemistry.

[57]  C. Swift,et al.  Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[58]  M. Díez,et al.  Oral bioavailability of levamisole in goats. , 2002, Journal of veterinary pharmacology and therapeutics.

[59]  Michael Levin.  Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .

[60]  Kristina Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .

[61]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[62]  F. Aoki,et al.  Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. , 2001, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[63]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.

[64]  P. Olliaro,et al.  Pharmacokinetics of Artemisinin-Type Compounds , 2000, Clinical pharmacokinetics.

[65]  I. Wilding,et al.  Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. , 2000, British journal of clinical pharmacology.

[66]  N. Idkaidek,et al.  Enhancement of oral absorption of metronidazole suspension in humans. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[67]  C. Clarke,et al.  Pharmacokinetics of acetazolimide after intravenous and oral administration in horses. , 2000, American journal of veterinary research.

[68]  N. White,et al.  Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria , 2000, Antimicrobial Agents and Chemotherapy.

[69]  M. Fromm,et al.  P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. , 2000, International journal of clinical pharmacology and therapeutics.

[70]  R. Polk,et al.  Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study , 1999, Antimicrobial Agents and Chemotherapy.

[71]  P. Sinko,et al.  Oral absorption of the HIV protease inhibitors: a current update. , 1999, Advanced drug delivery reviews.

[72]  R. Oberbauer,et al.  Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects. , 1999, British journal of clinical pharmacology.

[73]  D. Uges,et al.  Pharmacokinetics of high-dose oral and intravenous dexamethasone. , 1999, Therapeutic drug monitoring.

[74]  T. Macgregor,et al.  Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers , 1999, Biopharmaceutics & drug disposition.

[75]  N. White,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine , 1999 .

[76]  W. Prince,et al.  Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food , 1999, Pharmacotherapy.

[77]  P. Hu,et al.  The pharmacokinetics of lamivudine in healthy Chinese subjects. , 1999, British journal of clinical pharmacology.

[78]  K. Lamp,et al.  Pharmacokinetics and Pharmacodynamics of the Nitroimidazole Antimicrobials , 1999, Clinical pharmacokinetics.

[79]  P. Rolan,et al.  Simultaneous investigation of indinavir nonlinear pharmacokinetics and bioavailability in healthy volunteers using stable isotope labeling technique: study design and model-independent data analysis. , 1999, Journal of pharmaceutical sciences.

[80]  U. Hofmann,et al.  Chronopharmacology of intravenous and oral modified release verapamil. , 1999, British journal of clinical pharmacology.

[81]  G. E. Pakes,et al.  Clinical Pharmacokinetics of Lamivudine , 1999, Clinical pharmacokinetics.

[82]  S. Stavchansky,et al.  Link between drug absorption solubility and permeability measurements in Caco-2 cells. , 1998, Journal of pharmaceutical sciences.

[83]  A. Frick,et al.  Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[84]  A. Singh,et al.  Pharmacokinetics, bioavailability and dosage regimen of sulphadiazine (SDZ) in camels (Camelus dromedarius). , 1998, Journal of veterinary pharmacology and therapeutics.

[85]  C. Náquira,et al.  Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. , 1998, British journal of clinical pharmacology.

[86]  Ehrenpreis,et al.  Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis , 1998, Alimentary pharmacology & therapeutics.

[87]  S. Krähenbühl,et al.  Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. , 1998, British journal of clinical pharmacology.

[88]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[89]  R. Moreno-Esparza,et al.  Biopharmaceutics: Absorption Studies of Albendazole and Some Physicochemical Properties of the Drug and Its Metabolite Albendazole Sulphoxide , 1998, The Journal of pharmacy and pharmacology.

[90]  Susan Budavari,et al.  The Merck index , 1998 .

[91]  M. Dudley,et al.  Clinical Pharmacokinetics of Stavudine , 1997, Clinical pharmacokinetics.

[92]  R. Owens,et al.  Oral bioavailability and pharmacokinetics of ciprofloxacin in patients with AIDS , 1997, Antimicrobial agents and chemotherapy.

[93]  F. Péhourcq,et al.  Pharmacocinétique du méthotrexate dans la polyarthrite rhumatoïde : implications thérapeutiques , 1997 .

[94]  D. Cutler,et al.  Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects , 1997, Biological Psychiatry.

[95]  M. Murray,et al.  Variable Furosemide Absorption and Poor Predictability of Response in Elderly Patients , 1997, Pharmacotherapy.

[96]  B. Bannwarth,et al.  [Pharmacokinetics of methotrexate in rheumatoid arthritis: therapeutic implications]. , 1997, Therapie.

[97]  J. Barré,et al.  Food increases the bioavailability of mefloquine , 1997, European Journal of Clinical Pharmacology.

[98]  J. Karbwang,et al.  PHARMACOKINETICS AND DISPOSITION , 1997 .

[99]  W. Barron,et al.  Effect of food on the absorption of frusemide and bumetanide in man. , 2003, British journal of clinical pharmacology.

[100]  W. Jusko,et al.  Oral Absorption Characteristics and Pharmacokinetics of Colchicine in Healthy Volunteers after Single and Multiple Doses , 1996, Journal of clinical pharmacology.

[101]  D. Liberato,et al.  Plasma kinetics of vitamin A in humans after a single oral dose of [8,9,19-13C]retinyl palmitate. , 1996, Journal of lipid research.

[102]  M. Klepser,et al.  Oral Absorption of Trimethoprim‐Sulfamethoxazole in Patients with AIDS , 1996, Pharmacotherapy.

[103]  A. Zinsmeister,et al.  Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration. , 1996, Gut.

[104]  N. White,et al.  Pharmacokinetics of Quinine, Chloroquine and Amodiaquine , 1996, Clinical pharmacokinetics.

[105]  J. Galloway,et al.  Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. , 1996, The American journal of clinical nutrition.

[106]  D. Boulton,et al.  Enantioselective disposition of salbutamol in man following oral and intravenous administration. , 1996, British journal of clinical pharmacology.

[107]  U. Fuhr,et al.  Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine , 1996, European Journal of Clinical Pharmacology.

[108]  E. Hussey,et al.  Pharmacokinetics, Absolute Bioavailability, and Absorption Characteristics of Lamivudine , 1995, Journal of clinical pharmacology.

[109]  S. Tett,et al.  Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection , 1995, Antimicrobial agents and chemotherapy.

[110]  A. Renwick,et al.  Factors affecting the absolute bioavailability of nifedipine. , 1995, British journal of clinical pharmacology.

[111]  D Westerling,et al.  Plasma Concentrations of Morphine, Morphine‐3‐Glucuronide, and Morphine‐6‐Glucuronide After Intravenous and Oral Administration to Healthy Volunteers: Relationship to Nonanalgesic Actions , 1995, Therapeutic drug monitoring.

[112]  C. Zent,et al.  Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[113]  Y. Tam,et al.  Pharmacokinetics and Presystemic Gut Metabolism of Methyldopa in Healthy Human Subjects , 1995, Journal of clinical pharmacology.

[114]  I. Fong,et al.  Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients , 1995, Antimicrobial agents and chemotherapy.

[115]  P. Lücker,et al.  Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers. , 1994, Methods and findings in experimental and clinical pharmacology.

[116]  G. Menke,et al.  [Absolute bioavailability of folic acid after oral administration of a folic acid tablet formulation in healthy volunteers]. , 1994, Arzneimittel-Forschung.

[117]  H. Lennernäs,et al.  Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. , 1994, British journal of clinical pharmacology.

[118]  R. Alken,et al.  [Absolute bioavailability of chlorpromazine, promazine and promethazine]. , 1994, Arzneimittel-Forschung.

[119]  T. Vree,et al.  Pharmacokinetics and bioavailability of oral ergometrine in male volunteers , 1994, Biopharmaceutics & drug disposition.

[120]  M. Hays,et al.  Human thyroxine absorption: age effects and methodological analyses. , 1994, Thyroid : official journal of the American Thyroid Association.

[121]  J. Hasselström,et al.  Morphine Pharmacokinetics and Metabolism in Humans , 1993, Clinical pharmacokinetics.

[122]  G. Alván,et al.  The reproducibility of quinine bioavailability. , 1993, British journal of clinical pharmacology.

[123]  D. Church,et al.  Erratic zidovudine bioavailability in HIV seropositive patients. , 1993, The Journal of antimicrobial chemotherapy.

[124]  M. Shelton,et al.  Comparative Pharmacokinetics of Antiviral Nucleoside Analogues , 1993, Clinical pharmacokinetics.

[125]  荒井保明.  Pharmacokinetics , 1993 .

[126]  D. Debruyne,et al.  Clinical Pharmacokinetics of Fluconazole , 1993, Clinical pharmacokinetics.

[127]  K. Schrör,et al.  Klinische Pharmakologie von Acetylsalizylsäure , 1992 .

[128]  A. Lauer,et al.  Pharmacokinetics of intravenously and orally administered pyrimethamine in horses. , 1992, American journal of veterinary research.

[129]  I. Saavedra,et al.  [Phenytoin pharmacokinetics in young and older adults]. , 1992, Revista medica de Chile.

[130]  K. Mayer,et al.  Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex. , 1992, The Journal of infectious diseases.

[131]  J. Kisicki,et al.  The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. , 1992, Arthritis and rheumatism.

[132]  M. Rogge,et al.  Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses , 1992, Antimicrobial Agents and Chemotherapy.

[133]  W. Watson,et al.  The preadministration of activated charcoal and aspirin absorption. , 1992, Journal of toxicology. Clinical toxicology.

[134]  P. Hinderling,et al.  Pharmacokinetics of Digoxin and Main Metabolites/Derivatives in Healthy Humans , 1991, Therapeutic drug monitoring.

[135]  F. Sjöqvist,et al.  A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine. , 1991, British journal of clinical pharmacology.

[136]  L. Balant,et al.  Clinical Pharmacokinetics of Clomipramine , 1991, Clinical pharmacokinetics.

[137]  D. Chassard,et al.  Pharmacokinetics of pyrimethamine in healthy young volunteers using a new solid phase extraction/HPLC method. , 1991, European journal of drug metabolism and pharmacokinetics.

[138]  S. Ito,et al.  Disposition of single-dose intravenous and oral aspirin in children. , 1991, Developmental pharmacology and therapeutics.

[139]  J. Rotschafer,et al.  Clinical Pharmacokinetics of Ciprofloxacin , 1990, Clinical pharmacokinetics.

[140]  D. Back,et al.  Gastrointestinal metabolism of contraceptive steroids. , 1990, American journal of obstetrics and gynecology.

[141]  R. Cutler,et al.  Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Cimetidine in Seriously III Patients , 1990 .

[142]  J. Dubois,et al.  Absolute Bioavailability of Carbamazepine After Oral Administration of a 2% Syrup , 1990, Epilepsia.

[143]  T. Miyahara,et al.  Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects. , 1990, Clinical therapeutics.

[144]  W. Martin,et al.  Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man. , 1990, Biopharmaceutics & drug disposition.

[145]  J. K. Faulkner,et al.  Pharmacokinetics and tissue penetration of fluconazole in humans. , 1990, Reviews of infectious diseases.

[146]  L. Austin,et al.  Clomipramine: an antiobsessional tricyclic antidepressant. , 1990, Clinical pharmacy.

[147]  S. C. Forland,et al.  Pharmacokinetics and pharmacodynamics of oral and intravenous cimetidine in seriously ill patients. , 1990, Journal of clinical pharmacology.

[148]  M. Jann,et al.  Pharmacokinetics of Haloperidol , 1989, Clinical pharmacokinetics.

[149]  A. Arancibia,et al.  Pharmacokinetics of a nitrofuran compound, nifurtimox, in healthy volunteers. , 1989, International journal of clinical pharmacology, therapy, and toxicology.

[150]  A G Renwick,et al.  The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. , 1989, British journal of clinical pharmacology.

[151]  K. Venkatesan.  Clinical Pharmacokinetic Considerations in the Treatment of Patients with Leprosy , 1989, Clinical pharmacokinetics.

[152]  G. Aherne,et al.  The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. , 1989, British journal of clinical pharmacology.

[153]  U. Kunzendorf,et al.  Saturable First‐Pass Kinetics of Propranolol , 1989, Journal of clinical pharmacology.

[154]  D. Furst,et al.  Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. , 1989, Journal of pharmaceutical sciences.

[155]  M. Holdiness.  Clinical Pharmacokinetics of Clofazimine , 1989, Clinical pharmacokinetics.

[156]  G. Zaccara,et al.  Clinical Pharmacokinetics of Valproic Acid — 1988 , 1988, Clinical pharmacokinetics.

[157]  D. Church,et al.  Levamisole pharmacokinetics and bioavailability in dogs. , 1988, Research in veterinary science.

[158]  J. Riviere,et al.  Pharmacology and toxicology of doxycycline. , 1988, Veterinary and human toxicology.

[159]  Y. Tam,et al.  Linearity of metoclopramide kinetics at doses of 5-20 mg. , 1988, British journal of clinical pharmacology.

[160]  A. Mooradian,et al.  Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations. , 1988, Clinical pharmacokinetics.

[161]  A. Breckenridge,et al.  Clinical Pharmacokinetics of Anthelmintic Drugs , 1988, Clinical pharmacokinetics.

[162]  A. Nitenberg,et al.  Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. , 1988, The American journal of medicine.

[163]  B. H. Migdalof,et al.  Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases , 1988, Clinical pharmacokinetics.

[164]  J. Ferry,et al.  Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses , 1988, Journal of clinical pharmacology.

[165]  M. Lesne.  Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers. , 1988, Arzneimittel-Forschung.

[166]  S. Liao,et al.  Pharmacokinetics and bioavailability of zidovudine in humans. , 1988, The American journal of medicine.

[167]  B. Bannwarth,et al.  Clinical Pharmacokinetics of D-Penicillamine , 1987, Clinical pharmacokinetics.

[168]  D. Back,et al.  Comparative pharmacokinetics of levonorgestrel and ethinyloestradiol following intravenous, oral and vaginal administration. , 1987, Contraception.

[169]  J. Zuidema,et al.  The absolute oral bioavailability of dapsone in dogs and humans. , 1987, International journal of clinical pharmacology, therapy, and toxicology.

[170]  D. Alberts,et al.  Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial. , 1987, Cancer research.

[171]  V. Sunderland,et al.  Solubilities and intrinsic dissolution rates of sulphamethoxazole and trimethoprim , 1987, The Journal of pharmacy and pharmacology.

[172]  J. Dubois,et al.  Pharmacokinetics of clofazimine in healthy volunteers. , 1987, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[173]  S. Ziccone,et al.  Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. , 1986, British journal of clinical pharmacology.

[174]  F. Merkus,et al.  Influence of food on the bioavailability of spironolactone , 1986, Clinical pharmacology and therapeutics.

[175]  M. Eichelbaum,et al.  Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem , 1986, Clinical pharmacokinetics.

[176]  G. Murrell,et al.  Clinical Pharmacokinetics of Allopurinol , 1986, Clinical pharmacokinetics.

[177]  D. Westerlund,et al.  Clinical Pharmacokinetics of Co-Trimazine , 1986, Clinical pharmacokinetics.

[178]  P. Hartvig,et al.  Clinical Pharmacokinetics of Cholinesterase Inhibitors , 1986, Clinical pharmacokinetics.

[179]  C. T. Viswanathan,et al.  Pharmacokinetics of rifampin in children. II. Oral bioavailability. , 1986, Therapeutic drug monitoring.

[180]  L. Benet,et al.  The bioavailability of oral nitroglycerin. , 1986, Journal of pharmaceutical sciences.

[181]  D. Back,et al.  The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy. , 1986, Contraception.

[182]  J. Tukker,et al.  Bioavailability of paracetamol after oral administration to healthy volunteers. Influence of caffeine on rate and extent of absorption. , 1986, Pharmaceutisch weekblad. Scientific edition.

[183]  E. Karpenko,et al.  [Cimetidine pharmacokinetics]. , 1986, Farmakologiia i toksikologiia.

[184]  J. Faber,et al.  The bioavailability of thyroxine and 3,5,3'-triiodothyronine in normal subjects and in hyper- and hypothyroid patients. , 1985, Acta endocrinologica.

[185]  D. Paton,et al.  Clinical Pharmacokinetics of H1-Receptor Antagonists (The Antihistamines) , 1985, Clinical pharmacokinetics.

[186]  B. Kaufmann,et al.  Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N). , 1985, International journal of clinical pharmacology, therapy, and toxicology.

[187]  J. Mucklow,et al.  A comparative study of the bioavailability of five different phenytoin preparations , 1985, The Journal of pharmacy and pharmacology.

[188]  R. Galeazzi,et al.  Isosorbide dinitrate bioavailability, kinetics, and metabolism , 1985, Clinical pharmacology and therapeutics.

[189]  U. Klotz,et al.  Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid , 1985, Clinical pharmacokinetics.

[190]  V. Perrin.  Clinical Pharmacokinetics of Ergotamine in Migraine and Cluster Headache , 1985, Clinical pharmacokinetics.

[191]  H. Fung.  Pharmacokinetics and pharmacodynamics of isosorbide dinitrate. , 1985, American heart journal.

[192]  D. Alberts,et al.  Methotrexate: bioavailability and pharmacokinetics. , 1985, Cancer treatment reports.

[193]  A. Breckenridge,et al.  Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. , 1985, British journal of clinical pharmacology.

[194]  U. Maier,et al.  Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis , 1985, Clinical pharmacology and therapeutics.

[195]  I. F. Smith,et al.  Fat contents of meals and bioavailability of griseofulvin in man , 1985, The Journal of pharmacy and pharmacology.

[196]  P. Brooks,et al.  Clinical Pharmacokinetics of the Salicylates , 1985, Clinical pharmacokinetics.

[197]  L. Hollister,et al.  Elimination half-life and bioavailability of haloperidol in schizophrenic patients. , 1985, The Journal of clinical psychiatry.

[198]  M. Roberts,et al.  The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man. , 1985, British journal of clinical pharmacology.

[199]  B. Beermann.  Aspects on pharmacokinetics of some diuretics. , 2009, Acta pharmacologica et toxicologica.

[200]  G. FitzGerald,et al.  Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. , 1984, The New England journal of medicine.

[201]  M. Spino,et al.  Cloxacillin absorption and disposition in cystic fibrosis. , 1984, The Journal of pediatrics.

[202]  P. Workman,et al.  Preclinical pharmacokinetics of benznidazole. , 1984, British Journal of Cancer.

[203]  P. Ambrose.  Clinical Pharmacokinetics of Chloramphenicol and Chloramphenicol Succinate , 1984, Clinical pharmacokinetics.

[204]  L. Pickering,et al.  Comparative Bioavailability of Intravenous and Oral Chloramphenicol in Adults , 1984, Journal of clinical pharmacology.

[205]  R. Sohr,et al.  Untersuchungen zur Bioverfügbarkeit von Cyclophosphamid nach peroraler Applikation im hohen Dosisbereich , 1984 .

[206]  T. Wagner,et al.  Pharmacokinetics and bioavailability of cyclophosphamide from oral formulations. , 1984, Arzneimittel-Forschung.

[207]  R. Preiss,et al.  [Bioavailability of cyclophosphamide following oral administration in high doses]. , 1984, Onkologie.

[208]  I. Viano,et al.  Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers. , 1984, Arzneimittel-Forschung.

[209]  B. Nieuweboer,et al.  The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration. , 1984, International journal of clinical pharmacology, therapy, and toxicology.

[210]  A. Staib,et al.  A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets. , 1984, Arzneimittel-Forschung.

[211]  R. Blouin,et al.  Clinical Pharmacokinetics of Verapamil , 1984, Clinical pharmacokinetics.

[212]  L. Paalzow,et al.  Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. , 1983, British journal of clinical pharmacology.

[213]  D N Bateman,et al.  Clinical Pharmacokinetics of Metoclopramide , 1983, Clinical pharmacokinetics.

[214]  A. Somogyi,et al.  Clinical Pharmacokinetics of Cimetidine , 1983, Clinical pharmacokinetics.

[215]  W. Ritschel,et al.  Pilot study on the absolute and relative bioavailability of Synthroid and Levothroid, two brands of sodium levothyroxine. , 1983, International journal of clinical pharmacology, therapy, and toxicology.

[216]  D R Abernethy,et al.  Absolute and relative bioavailability of oral acetaminophen preparations. , 1983, Journal of pharmaceutical sciences.

[217]  O. Laskin.  Clinical Pharmacokinetics of Acyclovir , 1983, Clinical pharmacokinetics.

[218]  D. Stanski,et al.  Haloperidol kinetics after oral and intravenous doses , 1983, Clinical pharmacology and therapeutics.

[219]  B. Beermann,et al.  Disposition of chloroquine in man after single intravenous and oral doses. , 1983, British journal of clinical pharmacology.

[220]  J. Houston,et al.  Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man. , 1983, British journal of clinical pharmacology.

[221]  L. Paalzow,et al.  Optimal Routes of Administration of Ergotamine Tartrate in Cluster Headache Patients. A Pharmacokinetic Study* , 1983, Cephalalgia : an international journal of headache.

[222]  W. Kukovetz,et al.  Bioavailability and pharmacokinetics of D-penicillamine. , 1983, The Journal of rheumatology.

[223]  D. Greenblatt,et al.  Absolute Bioavailability of Oral and Intramuscular Diazepam: Effects of Age and Sex , 1983, Anesthesia and analgesia.

[224]  R. Urtasun,et al.  Human pharmacokinetics and toxicity of high-dose metronidazole administered orally and intravenously. , 1983, Surgery.

[225]  P. de Miranda,et al.  Pharmacokinetics of acyclovir after intravenous and oral administration. , 1983, The Journal of antimicrobial chemotherapy.

[226]  R. J. Allan,et al.  The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole. , 1982, British journal of clinical pharmacology.

[227]  E. Myhre,et al.  Clinical Pharmacokinetics of Methyldopa , 1982, Clinical pharmacokinetics.

[228]  S. Singhvi,et al.  Captopril kinetics , 1982, Clinical pharmacology and therapeutics.

[229]  D. Perrier,et al.  Phenobarbital Pharmacokinetics and Bioavailability in Adults , 1982, Journal of clinical pharmacology.

[230]  T. Bergan,et al.  Pharmacokinetics of phenoxymethylpenicillin in volunteers. , 1982, Chemotherapy.

[231]  J. Hansen,et al.  Clinical Pharmacokinetics of Antithyroid Drugs , 1981, Clinical pharmacokinetics.

[232]  P. McDonald,et al.  Absorption and bioavailability of oral erythromycin. , 1981, British journal of clinical pharmacology.

[233]  B. Hoener,et al.  Nitrofurantoin disposition , 1981, Clinical pharmacology and therapeutics.

[234]  E. Dickson,et al.  The pharmacokinetics of D-penicillamine in man. , 1981, Journal of Rheumatology Supplement.

[235]  T. Ludden,et al.  Hydralazine kinetics after single and repeated oral doses , 1980, Clinical pharmacology and therapeutics.

[236]  D. Bateman,et al.  The pharmacokinetics of metoclopramide in man with observations in the dog. , 1980, British journal of clinical pharmacology.

[237]  R. Miller,et al.  Pharmacokinetics and bioavailability of cimetidine in humans. , 1980, Journal of pharmaceutical sciences.

[238]  K. Sasahara,et al.  Dosage form design for improvement of bioavailability of levodopa II: bioavailability of marketed levodopa preparations in dogs and parkinsonian patients. , 1980, Journal of pharmaceutical sciences.

[239]  R. Gugler,et al.  Clinical Pharmacokinetics of Valproic Acid , 1980, Clinical pharmacokinetics.

[240]  P. Lundborg,et al.  Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. , 1979, British journal of clinical pharmacology.

[241]  H. M. Middleton.  In vivo absorption and phosphorylation of pyridoxine . HCl in rat jejunum. , 1979, Gastroenterology.

[242]  N. Clumeck,et al.  Clinical and pharmacological evaluation of different preparations of oral erythromycin. , 1979, Chemotherapy.

[243]  Marcela Gutová.  [Clinical pharmacology of acetylsalicylic acid]. , 1979, Ceskoslovenska pediatrie.

[244]  W. Löscher,et al.  Pharmacokinetics of ethosuximide in the dog. , 1978, Archives internationales de pharmacodynamie et de therapie.

[245]  J. Kanto,et al.  Methylergometrine (methylergonovine) concentrations in the human plasma and urine. , 1978, International journal of clinical pharmacology and biopharmacy.

[246]  J. O'grady,et al.  Effect of a standard breakfast on digoxin absorption in normal subjects , 1978, Clinical pharmacology and therapeutics.

[247]  Adams Jg.  Pharmacokinetics of levamisole. , 1978 .

[248]  J. G. Adams.  Pharmacokinetics of levamisole. , 1978, The Journal of rheumatology. Supplement.

[249]  T. Beveridge,et al.  Absolute bioavailability of digoxin tablets. , 1978, Arzneimittel-Forschung.

[250]  T R Bates,et al.  Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man. , 1977, Archives of dermatology.

[251]  E. Nüesch,et al.  Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man. , 1977, International journal of clinical pharmacology and biopharmacy.

[252]  A. Kallner,et al.  On the absorption of ascorbic acid in man. , 1977, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[253]  D. Hollander,et al.  Vitamin A1 intestinal absorption in vivo: influence of luminal factors on transport. , 1977, The American journal of physiology.

[254]  E. Iisalo.  Clinical Pharmacokinetics of Digoxin , 1977, Clinical pharmacokinetics.

[255]  D. Hollander,et al.  Vitamin K1 intestinal absorption in vivo: influence of luminal contents on transport. , 1977, The American journal of physiology.

[256]  K. Das,et al.  Clinical Pharmacokinetics of Sulphasalazine , 1976, Clinical pharmacokinetics.

[257]  M. Eichelbaum,et al.  Physiological disposition of verapamil in man. , 1976, Cardiovascular research.

[258]  H. Mattie,et al.  Dicloxacillin and cloxacillin: Pharmacokinetics in healthy and hemodialysis subjects , 1976, Clinical pharmacology and therapeutics.

[259]  D. Champion,et al.  Single-dose evaluation of a new enteric-coated aspirin preparation. , 1976, The Medical journal of Australia.

[260]  R. Gugler,et al.  Phenytoin: Pharmacokinetics and bioavailability , 1976, Clinical pharmacology and therapeutics.

[261]  A. Karim,et al.  Spironolactone. I. Disposition and metabolism , 1976, Clinical pharmacology and therapeutics.

[262]  R. Day,et al.  Evaluation of an enteric coated aspirin preparation. , 1976, Australian and New Zealand Journal of Medicine.

[263]  D. Greenblatt,et al.  Bioavailability of Drugs: The Digoxin Dilemma , 1976, Clinical pharmacokinetics.

[264]  I. Patel,et al.  Pharmacokinetic Properties of Ethosuximide in Monkeys. I. Single‐Dose Intravenous and Oral Administration , 1975, Epilepsia.

[265]  I. Patel,et al.  Pharmacokinetic Properties of Ethosuximide in Monkeys. II. Chronic Intravenous and Oral Administration , 1975, Epilepsia.

[266]  C. Ditzler,et al.  Bioavailability of oral dexamethasone , 1975, Clinical pharmacology and therapeutics.

[267]  L. Skovsted,et al.  The pharmacokinetics of propylthiouracil. , 2009, Acta pharmacologica et toxicologica.

[268]  D. Azarnoff,et al.  Absorption of digoxin from different oral preparations in normal subjects during steady state , 1974, Clinical pharmacology and therapeutics.

[269]  K. Florey,et al.  Analytical profiles of drug substances , 1972 .

[270]  J. Reynolds.  Martindale : the extra pharmacopoeia , 1972 .

[271]  S. Riegelman,et al.  Absorption characteristics of solid dispersed and micronized griseofulvin in man. , 1971, Journal of pharmaceutical sciences.

[272]  G. Ellard.  Absorption, metabolism and excretion of pyrazinamide in man. , 1969, Tubercle.

[273]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .

[274]  M. Murrell.  Digitalis , 1876, Edinburgh medical journal.